Who published this market news?

Dow Jones Newswires published this market news item.

Dow Jones Newswires

Kymera Therapeutics Is Maintained at Buy by B of A Securities

(15:07 GMT) Kymera Therapeutics Price Target Raised to $125.00/Share From $110.00 by B of A Securities

6/30/2026, 11:07 PM GMT+8 Dow Jones Newswires

(15:07 GMT) Kymera Therapeutics Price Target Raised to $125.00/Share From $110.00 by B of A Securities